THE CLINICAL-PHARMACOLOGY OF PAROXETINE IN HEALTHY-SUBJECTS

被引：14

作者：

RAPTOPOULOS, P

MCCLELLAND, GR

JACKSON, D

机构：

来源：

ACTA PSYCHIATRICA SCANDINAVICA | 1989年 / 80卷

关键词：

D O I：

10.1111/j.1600-0447.1989.tb07171.x

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：46 / 48

页数：3

共 7 条

[1]

LUND J, 1979, ACTA PHARMACOL TOX, V44, P289

[2] EFFECT OF IPRONIAZID AND IMIPRAMINE ON THE BLOOD PLATELET 5-HYDROXYTRYPTAMINE LEVEL IN MAN [J].

MARSHALL, EF ;

STIRLING, GS ;

TAIT, AC ;

TODRICK, A .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1960, 15 (01) :35-41

[3] EEG AND BLOOD LEVEL OF THE POTENTIAL ANTIDEPRESSANT PAROXETINE AFTER A SINGLE ORAL DOSE TO NORMAL VOLUNTEERS [J].

MCCLELLAND, GR ;

RAPTOPOULOS, P .

PSYCHOPHARMACOLOGY, 1984, 83 (04) :327-329

[4]

MCCLELLAND GR, 1985, BRIT J CLIN PHARMACO, V19, pP578

[5]

MORO F, 1981, ANN OPHTHALMOL, V13, P487

[6] POTENT DEPLETION OF 5HT FROM MONKEY WHOLE-BLOOD BY A NEW 5HT UPTAKE INHIBITOR, PAROXETINE (FG-7051) [J].

PETERSEN, EN ;

BECHGAARD, E ;

SORTWELL, RJ ;

WETTERBERG, L .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 52 (01) :115-119

[7] INHIBITION OF 5-HYDROXYTRYPTAMINE UPTAKE IN HUMAN-PLATELETS BY ANTI-DEPRESSANT AGENTS INVIVO [J].

ROSS, SB ;

APERIA, B ;

BECKFRIIS, J ;

JANSA, S ;

WETTERBERG, L ;

ABERG, A .

PSYCHOPHARMACOLOGY, 1980, 67 (01) :1-7

← 1 →